News
Media
Conferences
Publications
CME/CE
Resources
Subscribe
About
Partnerships

|Articles|April 19, 2012

35th Global Congress of Minimally Invasive Gynecology Title

Author(s)OBGYN.net Staff

35th Global Congress of Minimally Invasive Gynecology

Newsletter

Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.

Related Content

Bacterial vaginosis independently associated with increased STI co-infection | Image credit: stock.adobe.com

Bacterial vaginosis independently associated with increased STI co-infection

ByJoshua Fitch, Senior Editor

July 30th 2026

Michael Reed, MD, MSCP, on proposing sexual health as a pillar of women's health

Michael Reed, MD, MSCP, on proposing sexual health as a pillar of women's health

ByMichael A. Reed, MD, MSCP

July 28th 2026

FDA grants 510(k) clearance to Roche's cobas BV/CV assay

FDA grants 510(k) clearance to Roche's cobas BV/CV assay

ByJoshua Fitch, Senior Editor

July 24th 2026

A discussion of STI rates, barriers, and home screenings with Damian Alagia III, MD

A discussion of STI rates, barriers, and home screenings with Damian Alagia III, MD

ByDamian Alagia, III, MD, MS, MBA, FACS,

July 20th 2026

National strategy calls for $20B investment to close women's health gap | Image credit: stock.adobe.com

National strategy calls for $20B investment to close women's health gap

ByJoshua Fitch, Senior Editor

July 15th 2026

Latest CME

SimulatEd™: A Roadmap to Personalized Care Plans and Shared Decision-Making in Low-Grade Serous Ovarian Cancer

Case-based Simulation

SimulatEd™: A Roadmap to Personalized Care Plans and Shared Decision-Making in Low-Grade Serous Ovarian Cancer

Rachel N. Grisham, MD

Trending on Contemporary OB/GYN

Contemporary OB/GYN’s top expert interviews from July 2026

Joy Baker, MD, talks zuranolone's onset for postpartum depression

Bacterial vaginosis independently associated with increased STI co-infection

Top FDA & regulatory news you missed in July, from Contemporary OB/GYN

Jeffrey Jensen, MD, reacts to FDA approval of new contraception patch, Gwyn Lo